These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31319613)

  • 1. Harnessing Induced Essentiality: Targeting Carbonic Anhydrase IX and Angiogenesis Reduces Lung Metastasis of Triple Negative Breast Cancer Xenografts.
    Hedlund EE; McDonald PC; Nemirovsky O; Awrey S; Jensen LDE; Dedhar S
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31319613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
    Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production.
    Chafe SC; Lou Y; Sceneay J; Vallejo M; Hamilton MJ; McDonald PC; Bennewith KL; Möller A; Dedhar S
    Cancer Res; 2015 Mar; 75(6):996-1008. PubMed ID: 25623234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
    Ivanova L; Zandberga E; Siliņa K; Kalniņa Z; Ābols A; Endzeliņš E; Vendina I; Romanchikova N; Hegmane A; Trapencieris P; Eglītis J; Linē A
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):235-46. PubMed ID: 25422154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
    Dubois L; Peeters SG; van Kuijk SJ; Yaromina A; Lieuwes NG; Saraya R; Biemans R; Rami M; Parvathaneni NK; Vullo D; Vooijs M; Supuran CT; Winum JY; Lambin P
    Radiother Oncol; 2013 Sep; 108(3):523-8. PubMed ID: 23849171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC-0111, an inhibitor of carbonic anhydrase IX, attenuates hepatoblastoma cell viability and migration.
    Eloranta K; Pihlajoki M; Liljeström E; Nousiainen R; Soini T; Lohi J; Cairo S; Wilson DB; Parkkila S; Heikinheimo M
    Front Oncol; 2023; 13():1118268. PubMed ID: 36776327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically.
    Chafe SC; McDonald PC; Saberi S; Nemirovsky O; Venkateswaran G; Burugu S; Gao D; Delaidelli A; Kyle AH; Baker JHE; Gillespie JA; Bashashati A; Minchinton AI; Zhou Y; Shah SP; Dedhar S
    Cancer Immunol Res; 2019 Jul; 7(7):1064-1078. PubMed ID: 31088846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.
    Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L
    J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction.
    McDonald PC; Chafe SC; Dedhar S
    Front Cell Dev Biol; 2016; 4():27. PubMed ID: 27066484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UFH-001 cells: A novel triple negative, CAIX-positive, human breast cancer model system.
    Chen Z; Ai L; Mboge MY; McKenna R; Frost CJ; Heldermon CD; Frost SC
    Cancer Biol Ther; 2018 Jul; 19(7):598-608. PubMed ID: 29561695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.
    Güttler A; Theuerkorn K; Riemann A; Wichmann H; Kessler J; Thews O; Bache M; Vordermark D
    Oncol Rep; 2019 Apr; 41(4):2585-2594. PubMed ID: 30720123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper-Free 'Click' Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia.
    Tatiparti K; Sau S; Gawde KA; Iyer AK
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.
    van Kuijk SJ; Gieling RG; Niemans R; Lieuwes NG; Biemans R; Telfer BA; Haenen GR; Yaromina A; Lambin P; Dubois LJ; Williams KJ
    PLoS One; 2016; 11(8):e0161040. PubMed ID: 27513947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.
    Meehan J; Ward C; Turnbull A; Bukowski-Wills J; Finch AJ; Jarman EJ; Xintaropoulou C; Martinez-Perez C; Gray M; Pearson M; Mullen P; Supuran CT; Carta F; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2017 Jun; 8(26):42857-42875. PubMed ID: 28476026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
    Chen Z; Ai L; Mboge MY; Tu C; McKenna R; Brown KD; Heldermon CD; Frost SC
    PLoS One; 2018; 13(7):e0199476. PubMed ID: 29965974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside.
    McDonald PC; Chafe SC; Supuran CT; Dedhar S
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.
    Chinchar E; Makey KL; Gibson J; Chen F; Cole SA; Megason GC; Vijayakumar S; Miele L; Gu JW
    Vasc Cell; 2014; 6():12. PubMed ID: 24914410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.